Table 4.
Concentration of the molecules with concentration pretraining varying because of probiotic supplementation
| T0 or T1 Placebo Treatment | T1 Probiotics Treatment | P | |
|---|---|---|---|
| 2-Hydroxyisovalerate | 1.83 × 10−2 ± 1.64 × 10−2 | 1.37 × 10−2 ± 1.35 × 10−2 | 0.0469 |
| Trans-aconitate | 3.09 × 10−1 ± 2.45 × 10−1 | 1.67 × 10−1 ± 7.38 × 10−2 | 0.0451 |
| Citrate | 1.25 × 10−1 ± 2.43 × 10−1 | 9.71 × 10−2 ± 4.13 × 10−2 | 0.0733 |
| P-cresol sulfate | 3.60 × 10−2 ± 1.72 × 10−2 | 2.79 × 10−2 ± 1.81 × 10−2 | 0.0756 |
| Dimethyl sulfone | 3.90 × 10−1 ± 2.64 × 10−1 | 5.05 × 10−1 ± 3.03 × 10−1 | 0.0462 |
| Glycine | 8.28 × 10−1 ± 1.47 | 2.93 × 10−1 ± 1.16 × 10−1 | 0.0204 |
| Pantothenate | 1.60 × 10−1 ± 3.61 × 10−2 | 1.72 × 10−1 ± 3.83 × 10−2 | 0.0550 |
| Taurine | 3.23 ± 2.23 | 2.16 ± 1.38 | 0.0036 |
Values are means ± SD (in mM). For readability reasons, only comparisons characterized by P < 0.1 are reported.